# Gianni Bonadonna

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gianni-bonadonna/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,959 |
| Field | Breast Cancer Treatment Studies |
| h-index | 89 |
| i10-index | 277 |
| OpenAlex ID | https://openalex.org/A5023558260 |
| Works | 479 |

## Researcher papers

- [Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.](https://scholariq.org/papers/polychemotherapy-for-early-breast-cancer-an-overview-of-the-randomised-trials/)
- [Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer](https://scholariq.org/papers/combination-chemotherapy-as-an-adjuvant-treatment-in-operable-breast-cancer/)
- [Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials](https://scholariq.org/papers/long-term-outcomes-for-neoadjuvant-versus-adjuvant-chemotherapy-in-early-breast/)
- [High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma](https://scholariq.org/papers/high-dose-chemotherapy-and-autologous-bone-marrow-transplantation-compared-with/)
- [Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer](https://scholariq.org/papers/ten-year-experience-with-cmf-based-adjuvant-chemotherapy-in-resectable-breast/)
- [Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer](https://scholariq.org/papers/phase-iii-trial-evaluating-the-addition-of-paclitaxel-to-doxorubicin-followed-by/)
- [Conservation Surgery After Primary Chemotherapy in Large Carcinomas of the Breast](https://scholariq.org/papers/conservation-surgery-after-primary-chemotherapy-in-large-carcinomas-of-the/)
- [Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy](https://scholariq.org/papers/feasibility-and-tolerability-of-sequential-doxorubicin-paclitaxel-followed-by/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.